Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 916 AL 930

Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study

Sakurai H, Hanyu H, Sato T, Kume K, Hirao K, Kanetaka H, Iwamoto T.

Geriatr Gerontol Int. 2013 Jan;13(1):90-7. doi: 10.1111/j.1447-0594.2012.00866.x. Epub 2012 Jun 4.

Synaptic changes in Alzheimer's disease and its models

Pozueta J, Lefort R, Shelanski ML.

Neuroscience. 2013 Oct 22;251:51-65. doi: 10.1016/j.neuroscience.2012.05.050. Epub 2012 Jun 9.

Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease

Ooi L, Sidhu K, Poljak A, Sutherland G, O'Connor MD, Sachdev P, Münch G.

J Neural Transm (Vienna). 2013 Jan;120(1):103-11. doi: 10.1007/s00702-012-0839-2. Epub 2012 Jun 13.

The function of BMP4 during neurogenesis in the adult hippocampus in Alzheimer's disease

Xu H, Huang W, Wang Y, Sun W, Tang J, Li D, Xu P, Guo L, Yin ZQ, Fan X.

Ageing Res Rev. 2013 Jan;12(1):157-64. doi: 10.1016/j.arr.2012.05.002. Epub 2012 Jun 12.

Anesthetic effects in Alzheimer transgenic mouse models

Tang JX, Eckenhoff MF.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:167-71. doi: 10.1016/j.pnpbp.2012.06.007. Epub 2012 Jun 13.

A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial

Molloy DW, Standish TI, Zhou Q, Guyatt G; DARAD Study Group.

Int J Geriatr Psychiatry. 2013 May;28(5):463-70. doi: 10.1002/gps.3846. Epub 2012 Jun 21.

Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system

Kanaan NM, Pigino GF, Brady ST, Lazarov O, Binder LI, Morfini GA.

Exp Neurol. 2013 Aug;246:44-53. doi: 10.1016/j.expneurol.2012.06.003. Epub 2012 Jun 19.

Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation

Luan K, Rosales JL, Lee KY.

Ageing Res Rev. 2013 Jan;12(1):174-81. doi: 10.1016/j.arr.2012.06.002. Epub 2012 Jun 19.

Anesthesia, surgery, illness and Alzheimer's disease

Eckenhoff RG, Laudansky KF.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:162-6. doi: 10.1016/j.pnpbp.2012.06.011. Epub 2012 Jun 21.

Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT

Makedonov I, Black SE, MacIntosh BJ.

Eur J Neurol. 2013 Feb;20(2):243-50. doi: 10.1111/j.1468-1331.2012.03785.x. Epub 2012 Jun 28.

Tau protein kinases: involvement in Alzheimer's disease

Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, Terro F.

Ageing Res Rev. 2013 Jan;12(1):289-309. doi: 10.1016/j.arr.2012.06.003. Epub 2012 Jun 26.

A noradrenergic theory of cognitive reserve: implications for Alzheimer's disease

Robertson IH.

Neurobiol Aging. 2013 Jan;34(1):298-308. doi: 10.1016/j.neurobiolaging.2012.05.019. Epub 2012 Jun 27.

Exercise counteracts declining hippocampal function in aging and Alzheimer's disease

Intlekofer KA, Cotman CW.

Neurobiol Dis. 2013 Sep;57:47-55. doi: 10.1016/j.nbd.2012.06.011. Epub 2012 Jun 30.

A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes

Muñoz-Nieto M, Ramonet N, López-Gastón JI, Cuadrado-Corrales N, Calero O, Díaz-Hurtado M, Ipiens JR, Ramón y Cajal S, de Pedro-Cuesta J, Calero M.

J Neurol. 2013 Jan;260(1):77-84. doi: 10.1007/s00415-012-6588-1. Epub 2012 Jul 5.

Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A

Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F.

Ageing Res Rev. 2013 Jan;12(1):39-49. doi: 10.1016/j.arr.2012.06.008. Epub 2012 Jul 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias